Activity of linezolid against Gram-positive cocci: a multicentre study in Greek hospitals

International Journal of Antimicrobial Agents

Volumn 29, Issue 5, 2007, Pages 604-605

  Pratti, A ^a   Karanika, M ^a   Maniatis, A N ^a   Petinaki, E ^a   Spiliopoulou, I ^b   Kolonitsiou, F ^b   Tatsiopoulos, A ^c   Alexiou Daniel, S ^c   Bakola, D ^d   Koutsia Carousou, Ch ^e   Malamou Lada, H ^e   Siafakas, N ^f   Zerva, L ^f  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^d General Hospital of Lamia   (Greece)

^e IASO GENERAL HOSPITAL   (Greece)

^f UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENE MUTATION; GRAM POSITIVE COCCI; GREECE; HOSPITAL; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ACETAMIDES; ANTI-INFECTIVE AGENTS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GRAM-POSITIVE COCCI; GREECE; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES;

EID: 34147098648     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.12.005     Document Type: Letter

References (7)

1. Meka V.G., and Gold H.S. Antimicrobial resistance to linezolid. Clin Infect Dis 39 (2004) 1010-1015
2. Plouffe J.F. Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid. Clin Infect Dis 31 Suppl. 4 (2000) S144-S149
3. Burleson B.S., Ritchie D.J., Micek S.T., and Dune W.M. Enterococcus faecalis resistant to linezolid: case series and review of the literature. Pharmacotherapy 24 (2004) 1225-1231
4. National Committee for Clinical Laboratory Standards. MIC testing. Supplemental tables. M100-S13 (M7). Wayne, PA: NCCLS; 2003.
5. Bersos Z., Maniati M., Kontos F., Petinaki E., and Maniatis A.N. First report of a linezolid-resistant vancomycin-resistant Enterococcus faecium strain in Greece. J Antimicrob Chemother 53 (2004) 685-686
6. Anderegg T.R., Sader H.S., Fritsche T.R., Ross J.E., and Jones R.N. Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program. Int J Antimicrob Agents 26 (2005) 13-21
7. Jones R.N., Ross J.E., Fritsche T.R., and Sader H.S. Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. J Antimicrob Chemother 57 (2006) 279-287